Abstract
Clopidogrel resistance has been associated with increased periprocedural neurologic events after carotid artery stenting (CAS). Ticagrelor offers an improved resistance profile; however, its bleeding risk with CAS has not been assessed. We examined the safety and efficacy of perioperative dual antiplatelet therapy with aspirin (ASA) plus ticagrelor vs ASA plus clopidogrel in patients undergoing transfemoral CAS (TFCAS) or transcarotid artery revascularization (TCAR).
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call